Our study suggests that inhibition of CBS induces cell apoptosis, as well as limits cell proliferation and migration, a potential target for the treatment of chronic myeloid leukemia. The gene discussed is CBS; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.